Teresa Fu, MD
Dermatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fu’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A122147 · Current
Licensed to practise in California · since 2012 · expires 2027-11-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$152,546
Medicare paid this office $152,546 for 561 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 356 | $39,213 | $76 |
| Return visit (30+ min) | 160 | $21,189 | $112 |
| Destruction of precancer skin growth, 1 growth | 240 | $18,795 | $55 |
| Biopsy of related skin growth, first growth | 149 | $16,175 | $93 |
| Application of ultraviolet light to skin | 11 | $7,792 | $26 |
See all 16 services
| Short return visit (20+ min) | 356 | $39,213 | $76 |
| Return visit (30+ min) | 160 | $21,189 | $112 |
| Destruction of precancer skin growth, 1 growth | 240 | $18,795 | $55 |
| Biopsy of related skin growth, first growth | 149 | $16,175 | $93 |
| Application of ultraviolet light to skin | 11 | $7,792 | $26 |
| Destruction of precancer skin growth, 2-14 growths | 196 | $6,095 | $7 |
| Destruction of skin growth, 1-14 growths | 48 | $5,495 | $108 |
| New patient visit (45+ min) | 31 | $4,005 | $129 |
| New patient visit (30+ min) | 44 | $3,943 | $90 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $3,882 | $277 |
| Short return visit | 45 | $2,487 | $47 |
| Biopsy of related skin growth, each additional growth | 39 | $2,407 | $47 |
| Punch biopsy, first skin growth | 21 | $2,274 | $108 |
| Injection into skin growth, 1-7 growths | 15 | $1,401 | $47 |
| New patient visit (15+ min) | 16 | $994 | $62 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $41 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 45 | More than 85% of doctors who do this |
| Removal of skin lesions | 798 | More than 91% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 240 | More than 87% of doctors who do this |
Who their Medicare patients are
561 Original Medicare patients in 2024. Average age 75 · Women 60% · Also on Medicaid 4% · Health risk score 0.83. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 56% · Coronary heart disease 18% · Cancer 17% · Atrial fibrillation 16% · Diabetes 15% · Chronic kidney disease 15% · Depression 11% · Heart failure 8% · COPD 4% · Dementia 2% · Stroke 2%.
The office billed $584,953, Medicare allowed $212,936 and paid $152,546; for 2,890 services of 58 kinds; $430 of it was for drugs given in the office and $152,116 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 561 | 2,890 | 75 | 0.83 | $584,953 | $152,546 |
| 2023 | 470 | 2,154 | 76 | 0.90 | $458,863 | $126,119 |
| 2022 | 399 | 1,887 | 75 | 0.87 | $337,176 | $100,089 |
| 2021 | 440 | 2,016 | 75 | 0.84 | $391,302 | $116,994 |
| 2020 | 381 | 2,125 | 75 | 1.00 | $376,718 | $101,363 |
| 2019 | 422 | 1,993 | 75 | 1.04 | $388,220 | $100,983 |
| 2018 | 469 | 1,721 | 75 | 0.99 | $323,293 | $86,615 |
| 2017 | 316 | 1,459 | 72 | 1.82 | $151,963 | $44,539 |
| 2016 | 435 | 2,189 | 71 | 2.04 | $235,467 | $64,885 |
| 2015 | 65 | 175 | 70 | 2.46 | $22,504 | $6,877 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Short return visit (20+ min) | 293 | $31,131 | $75 |
| Return visit (30+ min) | 130 | $17,788 | $106 |
| Biopsy of related skin growth, first growth | 132 | $13,986 | $95 |
| Destruction of precancer skin growth, 1 growth | 188 | $13,631 | $55 |
| Destruction of skin growth, 1-14 growths | 45 | $5,330 | $113 |
| Destruction of precancer skin growth, 2-14 growths | 138 | $3,729 | $7 |
| New patient visit (30+ min) | 44 | $3,462 | $79 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 11 | $3,295 | $300 |
| New patient visit (45+ min) | 23 | $3,077 | $134 |
| Short return visit | 42 | $2,355 | $51 |
| Application of light to destroy precancer skin growth | 15 | $2,190 | $137 |
| Punch biopsy, first skin growth | 16 | $2,138 | $134 |
| Biopsy of related skin growth, each additional growth | 21 | $1,453 | $50 |
| Injection into skin growth, 1-7 growths | 17 | $1,026 | $45 |
| New patient visit (15+ min) | 14 | $861 | $62 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $21 | None |
2022: 12 services
| Short return visit (20+ min) | 259 | $25,724 | $80 |
| Return visit (30+ min) | 88 | $12,419 | $113 |
| Destruction of precancer skin growth, 1 growth | 150 | $10,484 | $57 |
| Biopsy of related skin growth, first growth | 86 | $8,944 | $97 |
| Destruction of skin growth, 1-14 growths | 38 | $4,422 | $111 |
| Destruction of precancer skin growth, 2-14 growths | 115 | $3,653 | $7 |
| New patient visit (30+ min) | 31 | $2,919 | $94 |
| New patient visit (45+ min) | 16 | $2,258 | $141 |
| Biopsy of related skin growth, each additional growth | 28 | $2,039 | $52 |
| Short return visit | 34 | $1,785 | $51 |
| Punch biopsy, first skin growth | 12 | $1,602 | $134 |
| New patient visit (15+ min) | 15 | $891 | $59 |
2021: 13 services
| Short return visit (20+ min) | 258 | $28,475 | $79 |
| Return visit (30+ min) | 117 | $17,274 | $110 |
| Biopsy of related skin growth, first growth | 100 | $10,872 | $99 |
| Destruction of precancer skin growth, 1 growth | 140 | $10,079 | $58 |
| Application of ultraviolet light to skin | 12 | $8,993 | $25 |
| New patient visit (30+ min) | 62 | $5,274 | $85 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $4,127 | $317 |
| Destruction of skin growth, 1-14 growths | 31 | $3,550 | $104 |
| Destruction of precancer skin growth, 2-14 growths | 112 | $3,249 | $7 |
| Short return visit | 52 | $2,595 | $46 |
| Punch biopsy, first skin growth | 14 | $1,772 | $127 |
| Biopsy of related skin growth, each additional growth | 22 | $1,530 | $46 |
| New patient visit (15+ min) | 13 | $863 | $66 |
2020: 17 services
| Short return visit (20+ min) | 259 | $21,252 | $59 |
| Return visit (30+ min) | 88 | $11,832 | $95 |
| Destruction of precancer skin growth, 1 growth | 174 | $10,611 | $50 |
| Biopsy of related skin growth, first growth | 84 | $8,702 | $91 |
| Application of ultraviolet light to skin | 13 | $7,038 | $23 |
| Destruction of skin growth, 1-14 growths | 39 | $4,508 | $110 |
| New patient visit (30+ min) | 53 | $4,114 | $78 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 15 | $4,007 | $267 |
| Destruction of precancer skin growth, 2-14 growths | 138 | $3,866 | $6 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 11 | $3,743 | None |
| Punch biopsy, first skin growth | 20 | $2,164 | $108 |
| Biopsy of related skin growth, each additional growth | 27 | $2,037 | $55 |
| Application of light to destroy precancer skin growth | 11 | $1,627 | $136 |
| New patient visit (15+ min) | 28 | $1,320 | $47 |
| Influenza vaccine split virus, preservative free | 12 | $732 | $61 |
| Short return visit | 17 | $647 | $36 |
| Administration of influenza virus vaccine | 12 | $247 | $21 |
2019: 12 services
| Short return visit (20+ min) | 246 | $23,628 | $64 |
| Biopsy of related skin growth, first growth | 104 | $10,817 | $89 |
| Destruction of precancer skin growth, 1 growth | 156 | $9,704 | $52 |
| Return visit (30+ min) | 73 | $8,088 | $89 |
| New patient visit (30+ min) | 94 | $6,993 | $74 |
| Destruction of skin growth, 1-14 growths | 53 | $5,559 | $98 |
| New patient visit (15+ min) | 50 | $2,994 | $60 |
| Destruction of precancer skin growth, 2-14 growths | 119 | $2,720 | $5 |
| Punch biopsy, first skin growth | 22 | $2,535 | $115 |
| Biopsy of related skin growth, each additional growth | 30 | $2,334 | $52 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $1,964 | $164 |
| Short return visit | 21 | $902 | $41 |
2018: 10 services
| Short return visit (20+ min) | 235 | $19,138 | $61 |
| Biopsy of single growth of skin and/or tissue | 138 | $13,874 | $92 |
| New patient visit (30+ min) | 140 | $10,444 | $75 |
| Destruction of precancer skin growth, 1 growth | 158 | $8,770 | $48 |
| Destruction of skin growth, 1-14 growths | 59 | $6,127 | $100 |
| Return visit (30+ min) | 50 | $5,170 | $96 |
| New patient visit (15+ min) | 48 | $2,825 | $59 |
| Destruction of precancer skin growth, 2-14 growths | 125 | $2,498 | $5 |
| Short return visit | 38 | $1,483 | $38 |
| Biopsy of each additional growth of skin and/or tissue | 24 | $1,070 | $30 |
2017: 13 services
| Short return visit (20+ min) | 128 | $7,435 | $46 |
| Destruction of precancer skin growth, 1 growth | 101 | $6,309 | $49 |
| New patient visit (30+ min) | 75 | $5,010 | $67 |
| Return visit (30+ min) | 50 | $4,589 | $70 |
| Return visit (30+ min) | 47 | $4,303 | $71 |
| Biopsy of single growth of skin and/or tissue | 71 | $2,895 | $35 |
| Destruction of precancer skin growth, 1 growth | 31 | $2,146 | $51 |
| Destruction of skin growth, 1-14 growths | 19 | $1,573 | $68 |
| Biopsy of single growth of skin and/or tissue | 28 | $1,116 | $33 |
| New patient visit (30+ min) | 15 | $1,018 | $68 |
| Biopsy of each additional growth of skin and/or tissue | 24 | $1,007 | $23 |
| Destruction of precancer skin growth, 2-14 growths | 83 | $919 | $2 |
| Destruction of precancer skin growth, 2-14 growths | 27 | $400 | $2 |
2016: 16 services
| Short return visit (20+ min) | 179 | $10,771 | $44 |
| Return visit (30+ min) | 60 | $7,704 | $69 |
| Destruction of precancer skin growth, 1 growth | 129 | $7,572 | $47 |
| New patient visit (30+ min) | 113 | $7,155 | $63 |
| Return visit (30+ min) | 63 | $5,952 | $65 |
| Destruction of precancer skin growth, 1 growth | 48 | $3,915 | $46 |
| Biopsy of single growth of skin and/or tissue | 89 | $3,473 | $35 |
| New patient visit (30+ min) | 33 | $2,170 | $66 |
| Biopsy of single growth of skin and/or tissue | 41 | $1,784 | $30 |
| Destruction of skin growth, 1-14 growths | 25 | $1,627 | $63 |
| Short return visit (20+ min) | 24 | $1,306 | $45 |
| Biopsy of each additional growth of skin and/or tissue | 23 | $1,280 | $22 |
| Biopsy of each additional growth of skin and/or tissue | 29 | $1,208 | $21 |
| New patient visit (15+ min) | 27 | $1,166 | $43 |
| Destruction of precancer skin growth, 2-14 growths | 114 | $1,116 | $2 |
| Destruction of precancer skin growth, 2-14 growths | 44 | $750 | $2 |
2015: 4 services
| New patient visit (30+ min) | 17 | $1,118 | $66 |
| Return visit (30+ min) | 11 | $773 | $70 |
| Short return visit (20+ min) | 14 | $722 | $45 |
| Destruction of precancer skin growth, 1 growth | 11 | $557 | $51 |
Drugs they prescribed that Part D paid
$258,843
Pharmacies billed $258,843 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
681 generic and 44 brand-name prescriptions · $258,843 in drug cost · 64 antibiotic prescriptions to 39 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Otezla | 18 | $86,416 | $4,801 |
| Rinvoq | 11 | $68,925 | $6,266 |
| Tacrolimus | 28 | $3,086 | $110 |
| Clobetasol Propionate | 42 | $1,760 | $42 |
| Fluocinonide | 44 | $1,654 | $38 |
See all 22 drugs
| Otezla | 18 | $86,416 | $4,801 |
| Rinvoq | 11 | $68,925 | $6,266 |
| Tacrolimus | 28 | $3,086 | $110 |
| Clobetasol Propionate | 42 | $1,760 | $42 |
| Fluocinonide | 44 | $1,654 | $38 |
| Fluorouracil | 23 | $1,351 | $59 |
| Triamcinolone Acetonide | 110 | $1,227 | $11 |
| Ketoconazole | 66 | $858 | $13 |
| Doxycycline Hyclate | 21 | $447 | $21 |
| Mometasone Furoate | 16 | $425 | $27 |
| Valacyclovir | 12 | $390 | $32 |
| Betamethasone Diprop Augmented | 37 | $331 | $9 |
| Ciclopirox | 11 | $290 | $26 |
| Minoxidil | 39 | $238 | $6 |
| Clindamycin Phosphate | 12 | $237 | $20 |
| Dutasteride | 11 | $170 | $15 |
| Doxycycline Monohydrate | 20 | $144 | $7 |
| Mupirocin | 21 | $141 | $7 |
| Fluconazole | 11 | $106 | $10 |
| Terbinafine | 20 | $102 | $5 |
| Hydrocortisone | 23 | $101 | $4 |
| Cephalexin | 12 | $35 | $3 |
Year by year
| 2024 | 725 | 295 | None | 6% | $258,843 |
| 2023 | 585 | 233 | None | 8% | $293,017 |
| 2022 | 511 | 206 | None | 8% | $159,711 |
| 2021 | 667 | 229 | None | 6% | $113,835 |
| 2020 | 567 | 209 | None | 9% | $114,843 |
| 2019 | 540 | 204 | None | 8% | $31,567 |
| 2018 | 462 | 224 | None | None | $34,183 |
| 2017 | 484 | 169 | 0% (0) | 11% | $43,526 |
| 2016 | 575 | 195 | None | None | $41,613 |
| 2015 | 92 | 41 | 0% (0) | 14% | $7,391 |
| 2014 | 16 | None | 0% (0) | 0% | $3,271 |
| 2013 | 76 | 33 | None | 20% | $23,065 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Rinvoq | 11 | $66,190 | $6,017 |
| Fluocinonide | 31 | $1,642 | $53 |
| Clobetasol Propionate | 35 | $1,266 | $36 |
| Ketoconazole | 50 | $1,249 | $25 |
| Fluorouracil | 12 | $1,130 | $94 |
| Valacyclovir | 14 | $1,081 | $77 |
| Triamcinolone Acetonide | 71 | $939 | $13 |
| Metronidazole | 11 | $677 | $62 |
| Dutasteride | 24 | $665 | $28 |
| Doxycycline Hyclate | 21 | $593 | $28 |
| Gabapentin | 36 | $509 | $14 |
| Betamethasone Diprop Augmented | 29 | $415 | $14 |
| Mupirocin | 26 | $269 | $10 |
| Clotrimazole-Betamethasone | 12 | $251 | $21 |
| Minoxidil | 16 | $180 | $11 |
| Hydrocortisone | 22 | $165 | $7 |
| Finasteride | 12 | $148 | $12 |
| Fluconazole | 11 | $115 | $10 |
2022: 15 drugs
| Otezla | 17 | $71,224 | $4,190 |
| Fluorouracil | 20 | $2,077 | $104 |
| Ketoconazole | 53 | $1,712 | $32 |
| Clobetasol Propionate | 31 | $1,671 | $54 |
| Fluocinonide | 22 | $1,655 | $75 |
| Doxycycline Hyclate | 31 | $1,463 | $47 |
| Betamethasone Diprop Augmented | 35 | $1,099 | $31 |
| Triamcinolone Acetonide | 63 | $925 | $15 |
| Dutasteride | 14 | $619 | $44 |
| Valacyclovir | 12 | $520 | $43 |
| Metronidazole | 11 | $512 | $47 |
| Methotrexate | 14 | $448 | $32 |
| Gabapentin | 29 | $269 | $9 |
| Mupirocin | 11 | $169 | $15 |
| Hydrocortisone | 17 | $113 | $7 |
2021: 19 drugs
| Otezla | 17 | $65,776 | $3,869 |
| Dapsone | 14 | $2,597 | $185 |
| Clobetasol Propionate | 25 | $2,526 | $101 |
| Betamethasone Dipropionate | 12 | $2,362 | $197 |
| Fluocinonide | 32 | $2,166 | $68 |
| Triamcinolone Acetonide | 129 | $1,851 | $14 |
| Ketoconazole | 60 | $1,843 | $31 |
| Valacyclovir | 24 | $1,591 | $66 |
| Fluorouracil | 15 | $1,497 | $100 |
| Doxycycline Hyclate | 34 | $1,459 | $43 |
| Halobetasol Propionate | 12 | $1,065 | $89 |
| Betamethasone Diprop Augmented | 54 | $987 | $18 |
| Tretinoin | 11 | $942 | $86 |
| Ciclopirox | 11 | $276 | $25 |
| Mupirocin | 25 | $209 | $8 |
| Terbinafine | 11 | $160 | $15 |
| Hydrocortisone | 18 | $114 | $6 |
| Gabapentin | 14 | $105 | $8 |
| Finasteride | 12 | $86 | $7 |
2020: 16 drugs
| Otezla | 18 | $65,197 | $3,622 |
| Fluorouracil | 32 | $3,250 | $102 |
| Betamethasone Dipropionate | 15 | $1,737 | $116 |
| Valacyclovir | 25 | $1,653 | $66 |
| Triamcinolone Acetonide | 118 | $1,545 | $13 |
| Fluocinonide | 30 | $1,455 | $49 |
| Betamethasone Diprop Augmented | 42 | $1,301 | $31 |
| Doxycycline Hyclate | 29 | $1,146 | $40 |
| Ketoconazole | 44 | $896 | $20 |
| Halobetasol Propionate | 12 | $797 | $66 |
| Clobetasol Propionate | 15 | $713 | $48 |
| Ciclopirox | 11 | $376 | $34 |
| Mupirocin | 21 | $177 | $8 |
| Hydrocortisone | 20 | $121 | $6 |
| Gabapentin | 15 | $49 | $3 |
| Cephalexin | 11 | $41 | $4 |
2019: 16 drugs
| Fluorouracil | 43 | $4,949 | $115 |
| Clobetasol Propionate | 33 | $2,883 | $87 |
| Fluocinonide | 55 | $2,526 | $46 |
| Calcipotriene | 12 | $2,081 | $173 |
| Triamcinolone Acetonide | 90 | $1,107 | $12 |
| Metronidazole | 12 | $1,003 | $84 |
| Betamethasone Dipropionate | 11 | $871 | $79 |
| Doxycycline Hyclate | 29 | $869 | $30 |
| Valacyclovir | 24 | $453 | $19 |
| Betamethasone Diprop Augmented | 16 | $450 | $28 |
| Nystatin | 16 | $417 | $26 |
| Ketoconazole | 27 | $414 | $15 |
| Ciclopirox | 13 | $315 | $24 |
| Mupirocin | 18 | $166 | $9 |
| Hydrocortisone | 16 | $103 | $6 |
| Terbinafine | 12 | $85 | $7 |
2018: 10 drugs
| Fluorouracil | 44 | $5,920 | $135 |
| Fluocinonide | 37 | $2,268 | $61 |
| Triamcinolone Acetonide | 105 | $1,401 | $13 |
| Tretinoin | 19 | $1,252 | $66 |
| Ketoconazole | 27 | $612 | $23 |
| Valacyclovir | 13 | $300 | $23 |
| Nystatin | 14 | $287 | $20 |
| Mupirocin | 20 | $236 | $12 |
| Hydrocortisone | 18 | $186 | $10 |
| Gabapentin | 12 | $158 | $13 |
2017: 13 drugs
| Acitretin | 21 | $19,499 | $929 |
| Fluocinonide | 59 | $4,342 | $74 |
| Fluorouracil | 37 | $4,174 | $113 |
| Clobetasol Propionate | 13 | $2,070 | $159 |
| Triamcinolone Acetonide | 84 | $1,293 | $15 |
| Doxycycline Hyclate | 22 | $1,163 | $53 |
| Tretinoin | 12 | $894 | $74 |
| Clindamycin Phosphate | 18 | $845 | $47 |
| Ketoconazole | 32 | $717 | $22 |
| Ciclopirox | 16 | $521 | $33 |
| Polyethylene Glycol 3350 | 12 | $206 | $17 |
| Hydrocortisone | 34 | $182 | $5 |
| Mupirocin | 18 | $139 | $8 |
2016: 11 drugs
| Fluorouracil | 73 | $11,993 | $164 |
| Clobetasol Propionate | 21 | $4,436 | $211 |
| Fluocinonide | 59 | $3,793 | $64 |
| Triamcinolone Acetonide | 100 | $2,006 | $20 |
| Tretinoin | 14 | $1,702 | $122 |
| Clindamycin Phosphate | 20 | $1,414 | $71 |
| Ketoconazole | 40 | $785 | $20 |
| Doxycycline Hyclate | 11 | $736 | $67 |
| Hydrocortisone | 58 | $445 | $8 |
| Ciclopirox | 16 | $372 | $23 |
| Mupirocin | 22 | $178 | $8 |
2015: 2 drugs
| Fluorouracil | 19 | $4,195 | $221 |
| Triamcinolone Acetonide | 22 | $384 | $17 |
2013: 2 drugs
| Fluocinonide | 16 | $876 | $55 |
| Triamcinolone Acetonide | 18 | $706 | $39 |
Money from drug and device companies
$2,076 in 2025
| 2025 | 15 | 88 | None | $2,076 |
| 2024 | 13 | 49 | None | $1,248 |
| 2023 | 9 | 28 | None | $721 |
| 2022 | 5 | 6 | None | $151 |
| 2021 | 1 | 1 | None | $12 |
| 2020 | 2 | 3 | None | $61 |
| 2019 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arcutis Biotherapeutics | Zoryve | $488 | 17 payments
|
| Galderma Laboratories L.P. | Nemluvio | $227 | 10 payments
|
| Janssen Biotech | Tremfya | $204 | 7 payments
|
| LEO Pharma | Adbry | $174 | 9 payments
|
| Lilly USA | Taltz | $168 | 6 payments
|
| Regeneron Healthcare Solutions | Dupixent | $168 | 9 payments
|
See all 88 published payments
| LEO Pharma | Meals · 2025-12-19 | Adbry | $15 |
| LEO Pharma | Meals · 2025-12-19 | Adbry | $15 |
| Novartis Pharmaceuticals | Meals · 2025-12-12 | Cosentyx | $29 |
| Ucb | Meals · 2025-12-12 | Bimzelx | $37 |
| LEO Pharma | Meals · 2025-12-11 | Adbry | $15 |
| LEO Pharma | Meals · 2025-12-11 | Adbry | $15 |
| Galderma Laboratories L.P. | Meals · 2025-12-05 | Nemluvio | $15 |
| Novartis Pharmaceuticals | Meals · 2025-12-04 | Cosentyx | $24 |
| Ucb | Meals · 2025-12-02 | Bimzelx | $30 |
| Incyte | Meals · 2025-11-27 | Opzelura | $29 |
| Arcutis Biotherapeutics | Meals · 2025-11-24 | Zoryve | $25 |
| Galderma Laboratories L.P. | Meals · 2025-11-21 | Nemluvio | $3 |
| Arcutis Biotherapeutics | Meals · 2025-11-21 | Zoryve | $8 |
| Sun Pharmaceutical Industries | Meals · 2025-11-17 | Winlevi | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-11-15 | Dupixent | $26 |
| Arcutis Biotherapeutics | Meals · 2025-11-13 | Zoryve | $181 |
| LEO Pharma | Meals · 2025-11-07 | Adbry | $26 |
| LEO Pharma | Meals · 2025-10-24 | Adbry | $21 |
| Abbvie | Meals · 2025-10-23 | Skyrizi | $9 |
| Genzyme | Meals · 2025-10-23 | Dupixent | $34 |
| Arcutis Biotherapeutics | Meals · 2025-10-23 | Zoryve | $19 |
| Incyte | Meals · 2025-10-17 | Opzelura | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-10-16 | Dupixent | $27 |
| Regeneron Healthcare Solutions | Meals · 2025-10-14 | Dupixent | $14 |
| LEO Pharma | Meals · 2025-10-10 | Adbry | $25 |
| Galderma Laboratories L.P. | Meals · 2025-10-09 | Nemluvio | $36 |
| Galderma Laboratories L.P. | Meals · 2025-10-09 | Nemluvio | $0 |
| Arcutis Biotherapeutics | Meals · 2025-10-07 | Zoryve | $21 |
| Arcutis Biotherapeutics | Meals · 2025-09-30 | Zoryve | $5 |
| Abbvie | Meals · 2025-09-27 | Skyrizi | $14 |
| Abbvie | Meals · 2025-09-24 | Rinvoq | $24 |
| Regeneron Healthcare Solutions | Meals · 2025-09-23 | Dupixent | $18 |
| Ucb | Meals · 2025-09-18 | Bimzelx | $16 |
| Organon | Meals · 2025-09-16 | Vtama | $26 |
| LEO Pharma | Meals · 2025-09-11 | Adbry | $21 |
| Galderma Laboratories L.P. | Meals · 2025-09-09 | Nemluvio | $21 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $22 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $0 |
| Janssen Biotech | Meals · 2025-09-04 | Tremfya | $4 |
| Abbvie | Meals · 2025-09-02 | Skyrizi | $32 |
| Organon | Meals · 2025-08-29 | Vtama | $9 |
| Organon | Meals · 2025-08-29 | Vtama | $25 |
| Galderma Laboratories L.P. | Meals · 2025-08-28 | Nemluvio | $38 |
| Arcutis Biotherapeutics | Meals · 2025-08-28 | Zoryve | $6 |
| Janssen Biotech | Meals · 2025-08-27 | Tremfya | $16 |
| LEO Pharma | Meals · 2025-08-26 | Adbry | $21 |
| Abbvie | Meals · 2025-08-21 | Skyrizi | $28 |
| Janssen Biotech | Education · 2025-08-14 | Tremfya | $100 |
| Lilly USA | Meals · 2025-08-07 | Taltz | $29 |
| Lilly USA | Meals · 2025-08-05 | Ebglyss | $27 |
| Arcutis Biotherapeutics | Meals · 2025-08-01 | Zoryve | $19 |
| Genzyme | Meals · 2025-07-31 | Dupixent | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-07-29 | Dupixent | $17 |
| Amgen | Meals · 2025-07-14 | Otezla | $31 |
| Arcutis Biotherapeutics | Meals · 2025-07-14 | Zoryve | $7 |
| Almirall | Meals · 2025-06-17 | Klisyri | $21 |
| Janssen Biotech | Meals · 2025-06-12 | Tremfya | $32 |
| Incyte | Meals · 2025-06-10 | Opzelura | $30 |
| Incyte | Meals · 2025-05-29 | Opzelura | $4 |
| Galderma Laboratories L.P. | Meals · 2025-05-29 | Nemluvio | $34 |
| Incyte | Meals · 2025-05-28 | Opzelura | $7 |
| Incyte | Meals · 2025-05-28 | Opzelura | $7 |
| Arcutis Biotherapeutics | Meals · 2025-05-23 | Zoryve | $15 |
| Galderma Laboratories L.P. | Meals · 2025-05-22 | Nemluvio | $29 |
| Abbvie | Meals · 2025-05-21 | Rinvoq | $12 |
| Abbvie | Meals · 2025-05-21 | Rinvoq | $17 |
| Lilly USA | Meals · 2025-05-06 | Taltz | $23 |
| Incyte | Meals · 2025-05-02 | Opzelura | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-04-29 | Dupixent | $18 |
| Arcutis Biotherapeutics | Meals · 2025-04-29 | Zoryve | $3 |
| Incyte | Meals · 2025-04-18 | Opzelura | $20 |
| Arcutis Biotherapeutics | Meals · 2025-03-28 | Zoryve | $23 |
| Arcutis Biotherapeutics | Meals · 2025-03-27 | Zoryve | $25 |
| Arcutis Biotherapeutics | Meals · 2025-03-25 | Zoryve | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-03-21 | Dupixent | $18 |
| Galderma Laboratories L.P. | Meals · 2025-03-21 | Nemluvio | $31 |
| Regeneron Healthcare Solutions | Education · 2025-03-20 | Dupixent | $7 |
| Galderma Laboratories L.P. | Meals · 2025-03-11 | Nemluvio | $21 |
| Ucb | Meals · 2025-02-28 | Bimzelx | $22 |
| Organon | Meals · 2025-02-28 | Vtama | $17 |
| Arcutis Biotherapeutics | Meals · 2025-02-28 | Zoryve | $71 |
| Lilly USA | Meals · 2025-02-11 | Ebglyss | $25 |
| Regeneron Healthcare Solutions | Meals · 2025-02-06 | Dupixent | $24 |
| Janssen Biotech | Meals · 2025-01-23 | Tremfya | $29 |
| Lilly USA | Meals · 2025-01-16 | Taltz | $33 |
| Arcutis Biotherapeutics | Meals · 2025-01-13 | Zoryve | $12 |
| Lilly USA | Meals · 2025-01-03 | Taltz | $31 |
| Arcutis Biotherapeutics | Meals · 2025-01-03 | Zoryve | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,248
| Janssen Biotech | Tremfya | $241 | 9 payments
|
| Amgen | Otezla | $219 | 7 payments
|
| Incyte | Opzelura | $136 | 8 payments
|
| Lilly USA | Taltz | $104 | 4 payments
|
| Abbvie | Skyrizi | $101 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $93 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $86 | 4 payments
|
| Pfizer | Eucrisa | $72 | 3 payments
|
| Novartis Pharmaceuticals | Xolair | $60 | 2 payments
|
| Arcutis Biotherapeutics | Zoryve | $50 | 2 payments
|
| Galderma Laboratories L.P. | None | $49 | 2 payments
|
| Dermavant Sciences | Vtama | $23 | 1 payment
|
| LEO Pharma | Adbry | $14 | 1 payment
|
2023: $721
| Abbvie | Skyrizi | $161 | 7 payments
|
| Janssen Biotech | Tremfya | $140 | 5 payments
|
| Amgen | Otezla | $98 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $88 | 4 payments
|
| Dermavant Sciences | Vtama | $60 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $56 | 2 payments
|
| LEO Pharma | Adbry | $56 | 2 payments
|
| Pfizer | Eucrisa | $32 | 2 payments
|
| Arcutis Biotherapeutics | None | $30 | 1 payment
|
2022: $151
| Regeneron Healthcare Solutions | Dupixent | $56 | 2 payments
|
| LEO Pharma | Adbry | $26 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $24 | 1 payment
|
| Incyte | Opzelura | $24 | 1 payment
|
| Genzyme | Fabrazyme | $21 | 1 payment
|
2021: $12
| AbbVie | Skyrizi | $12 | 1 payment
|
2020: $61
| AbbVie | Skyrizi | $40 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $21 | 1 payment
|
2019: $23
| Sun Pharmaceutical Industries | Ilumya | $23 | 1 payment
|
Professional record
- NPI
- 1164716619
- Licence
- CA A122147California A122147: Current · expires 2027-11-30
- Trained
- Stanford University School of Medicine, 2011
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2011-06-01
- NPI last updated
- 2020-06-11
- NPI record certified
- 2020-06-11
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305